Cargando…

Tocilizumab in the treatment of rheumatoid arthritis and beyond

Rheumatoid arthritis (RA) is a systemic inflammatory disease characterized by joint pain, swelling, stiffness, and progressive destruction of the small joints of the hands and feet. Treatment of RA has improved over the past decade. With multiple cytokines well-known now to play a role in the pathog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetty, Anjali, Hanson, Rebekah, Korsten, Peter, Shawagfeh, Munir, Arami, Shiva, Volkov, Suncica, Vila, Olga, Swedler, William, Shunaigat, Abdel Naser, Smadi, Sameer, Sawaqed, Ray, Perkins, David, Shahrara, Shiva, Sweiss, Nadera J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3974690/ https://www.ncbi.nlm.nih.gov/pubmed/24729685 http://dx.doi.org/10.2147/DDDT.S41437

Ejemplares similares

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010)

Metabolic regulation of RA macrophages is distinct from RA fibroblasts and blockade of glycolysis alleviates inflammatory phenotype in both cell types
por: Umar, Sadiq, et al.
Publicado: (2021)

Increased Whole Blood Viscosity Is Associated with the Presence of Digital Ulcers in Systemic Sclerosis: Results from a Cross-Sectional Pilot Study
por: Korsten, Peter, et al.
Publicado: (2017)

Editorial: Sarcoidosis—The great mimicker
por: Korsten, Peter, et al.
Publicado: (2022)

Prevalence of stress urinary incontinence and its impact on quality of life among women in Jordan: a correlational study
por: Sawaqed, Fadi, et al.
Publicado: (2020)

Response
por: Sweiss, Nadera J., et al.
Publicado: (2021)

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review
por: Sweis, Jaleel Jerry G., et al.
Publicado: (2022)

IgA Anti-β2-Glycoprotein I Autoantibodies Are Associated with an Increased Risk of Thromboembolic Events in Patients with Systemic Lupus Erythematosus
por: Sweiss, Nadera J., et al.
Publicado: (2010)

Idiopathic combined, autoantibody-mediated ADAMTS-13/factor H deficiency in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in a 17-year-old woman: a case report
por: Patschan, Daniel, et al.
Publicado: (2011)

Reproducibility and rigor in rheumatology research
por: Alnaimat, Fatima, et al.
Publicado: (2023)

Corrigendum: Reproducibility and rigor in rheumatology research
por: Alnaimat, Fatima, et al.
Publicado: (2023)

TH-17 cells in rheumatoid arthritis
por: Shahrara, Shiva, et al.
Publicado: (2008)

Differential expression of the FAK family kinases in rheumatoid arthritis and osteoarthritis synovial tissues
por: Shahrara, Shiva, et al.
Publicado: (2007)

Case Series: COVID-19 in African American Patients With Sarcoidosis
por: Manansala, Michael, et al.
Publicado: (2020)

Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue
por: Shahrara, Shiva, et al.
Publicado: (2002)

Treatment of Periorbital Edema in a Patient With Systemic Lupus Erythematosus During Pregnancy: A Case Report Written With the Assistance of ChatGPT
por: Jansz, Jacqueline, et al.
Publicado: (2023)

Pitfalls in the Diagnosis and Management of an Unusual Presentation of Clinically Amyopathic Dermatomyositis: A Case Report Written With the Assistance of ChatGPT
por: Jansz, Jacqueline, et al.
Publicado: (2023)

T-cell Large Granular Lymphocytic Leukemia and Felty Syndrome in Rheumatoid Arthritis: A Case Report
por: Prasad, Supritha, et al.
Publicado: (2023)

Management of extrapulmonary sarcoidosis: challenges and solutions
por: Al-Kofahi, Khalid, et al.
Publicado: (2016)

Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations
por: Sweiss, Nadera J., et al.
Publicado: (2010)

Correction: Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease Manifestations
por: Sweiss, Nadera J., et al.
Publicado: (2010)

COVID-19 and Sarcoidosis, Readiness for Vaccination: Challenges and Opportunities
por: Manansala, Michael, et al.
Publicado: (2021)

Regulation of inflammatory immune responses leading to the development of bone destructive autoimmune disease rheumatoid arthritis by IL-27
por: Yoshimoto, Takayuki, et al.
Publicado: (2012)

Cardiovascular disease risk evaluation impact in patients with rheumatoid arthritis
por: Aronov, Avi, et al.
Publicado: (2022)

Jordanian Use of and Beliefs Concerning the Efficacy of Medicinal Plants: A Cross-Sectional Study
por: Sweiss, Kanar, et al.
Publicado: (2023)

Gene Co-expression Networks Identifies Common Hub Genes Between Cutaneous Sarcoidosis and Discoid Lupus Erythematosus
por: Nickles, Melissa A., et al.
Publicado: (2020)

Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis
por: Ruth, Jeffrey H, et al.
Publicado: (2010)

Is there any association between contrast-induced nephropathy and serum uric acid levels?
por: Mirbolouk, Fardin, et al.
Publicado: (2021)

Full-Thickness Eyelid Lesions in Sarcoidosis
por: Collins, Megan E., et al.
Publicado: (2013)

Association of Neutrophil to Lymphocyte Ratio and Pulmonary Hypertension in Sarcoidosis Patients
por: Mirsaeidi, Mehdi, et al.
Publicado: (2016)

Treatment of COVID-19 in Patients With Sarcoidosis
por: Kondle, Shreya, et al.
Publicado: (2021)

Altered transcription factor targeting is associated with differential peripheral blood mononuclear cell proportions in sarcoidosis
por: Ascoli, Christian, et al.
Publicado: (2022)

Repository corticotropin for Chronic Pulmonary Sarcoidosis
por: Baughman, Robert P., et al.
Publicado: (2017)

Bacterial meningitis in a patient with multiple sclerosis receiving Tysabri
por: Moghadasi, Abdorreza Naser, et al.
Publicado: (2016)

Efficacy and safety of Tocilizumab, plasmapheresis and their combination in severe COVID-19: A randomized clinical trial
por: Gholinataj jelodar, Mohsen, et al.
Publicado: (2023)

Dilemma of Tocilizumab therapy for a patient with critical COVID‐19 disease and neutropenia: Case report and review of the literature
por: Al Bishawi, Ahmad, et al.
Publicado: (2022)

Tocilizumab and COVID-19
por: Chaudhry, Dhruva, et al.
Publicado: (2020)

Unsupervised Clustering Reveals Sarcoidosis Phenotypes Marked by a Reduction in Lymphocytes Relate to Increased Inflammatory Activity on 18FDG-PET/CT
por: Vagts, Christen, et al.
Publicado: (2021)

Favorable Outcome of COVID-19 Pneumonia in a Kidney Transplant Recipient Treated with Tocilizumab
por: Guella, Adnane, et al.
Publicado: (2020)

Inhibition of IRAK4 dysregulates SARS-CoV-2 spike protein-induced macrophage inflammatory and glycolytic reprogramming
por: Umar, Sadiq, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dqbdnlutnp6beubsup2gn0of20